FIELD: organic chemistry, biochemistry, medicine, pharmacy.
SUBSTANCE: invention relates to new derivatives of 3-aminomethylquinolone-2 of the general formula (1)
(2)
or (3) wherein R1 means hydrogen atom (H) or Alk; R2 is taken among Alk; -OAlk, -SCH3, -Hal, -CF3, 3,4-OCH2CH2O-, 3,4-OCH2O-, 4-OCF3, 2-Ph, -OPh, -NHCOR, 2-OCH3, 5-Ph, 4-Obzk, 3-NO2, 2-CH3, 5-iPr, di-OAlk, di-Hal; or R2 represents halogen atom and alkyl group, or halogen atom and alkoxy-group taken simultaneously and independently of one another; or R2 represents the group -CONR4R5 wherein each R4 and R5 means independently of one another the group Alk, or they form the group -(CH2)n- wherein n = 2-6. R means -CH3; R3 means hydrogen atom (H); X is taken among hydrogen atom (H), 6-(C1-C3)-Alk, 6-iPr, 6-iBu; 7-(C1-C2)-Alk, 8-(C1-C2)-Alk, 6-(C1-C2)-OAlk, 6-OCF3, 7-(C1-C2)-Alk, 7-SCH3, 6,7-OCH2O-, 6,7-OCH2CH2O-, 5,6,7-OCH3, 6-F; X and Y are similar or different and taken among 7,8-CH3, 6,8-CH3, 5,8-CH3, 5,7-CH3, 6,7-CH3, 6,7-OCH3, 6-CH3, 7-Cl. Also, invention relates to a method for preparing indicated compounds and to pharmaceutical composition inhibiting activity of NO-synthetase based on these compounds. Invention provides preparing new compounds and pharmaceutical composition based on thereof for aims preparing medicinal agents for treatment diseases associated with hyperactivity of phagocytizing cells, for example, rheumatic arthritis, asthma and others.
EFFECT: improved preparing method, valuable medicinal and biochemical properties of compounds and pharmaceutical composition.
19 cl, 1 tbl, 95 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF PHENYL-3-AMINOMETHYLQUINOLONE-2 AS INHIBITORS OF NO-SYNTHASE, METHOD FOR THEIR PREPARING, BIOLOGICALLY ACTIVE COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2003 |
|
RU2284325C2 |
COMPOUNDS USEFUL AS TRPM8 MODULATORS | 2011 |
|
RU2608109C2 |
TRIALLILBORANE ADDUCTS WITH AMMONIA AND AMINES AS ALLYLATING REAGENTS | 2018 |
|
RU2678208C1 |
[N'-(ISO)QUINOLYLMETHYLENE]HYDRAZIDES OF 3-METHOXY-13,17-SECOESTRA-1,3,5(10)-TRIEN-17-OIC ACID | 2023 |
|
RU2801166C1 |
QUINOLINE-2 DERIVATIVES AS C-KIT KINASE INHIBITORS | 2016 |
|
RU2754858C2 |
DIAPHRAGM-FREE ELECTROSYNTHESIS OF SUBSTITUTED PYRIDO[1,2-a]BENZIMIDAZOLES | 2014 |
|
RU2556001C1 |
SUBSTITUTED 2-METHYLIDEN-5-(PHENYLAMINO)-2,3-DIHYDROTIOPHEN-3-ONE FOR TREATMENT OF LEUKEMIAS WITH TRANSLOCATIONS OF MLL-GENE AND OTHER ONCOLOGICAL DISEASES | 2017 |
|
RU2656603C1 |
METHOD OF OBTAINING 7-R-PYRIDO[1,2-a]BENZIMIDAZOLES | 2012 |
|
RU2522549C1 |
TLR7/8 ANTAGONISTS AND THEIR APPLICATION | 2017 |
|
RU2758686C2 |
METHOD OF PRODUCING N-((HYDROXYAMINO)-OXOALKYL)-2-(QUINAZOLIN-4-YLAMINO)-BENZAMIDES | 2019 |
|
RU2722694C1 |
Authors
Dates
2006-01-10—Published
2003-10-07—Filed